James R. Kasinger, General Counsel and Secretary at CRISPR Therapeutics AG (CRSP), sold 2,152 shares at $66.60 ($143K) on 2025-10-14, disclosed to the SEC on 2025-10-15.
Open-market sale of $143k CRSP by General Counsel and Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $66.60 | 1,076 | $72K | 50.0% |
| 2 | $66.60 | 1,076 | $72K | 50.0% |
| Total | $66.60 avg | 2,152 | $143K | 100% |
| Filing → |
| CRSP | SELL | 2026-03-17 | $166K | — | Filing → |
| CRSP | SELL | 2026-03-12 | $148K | — | Filing → |
| CRSP | SELL | 2026-02-20 | $111K | — | Filing → |